HomeBest options strategy › ARVN

Best Options Strategy for ARVN

By Yojana Mandon · Updated 2026 · 2 min read · Risk disclaimer

Looking for the best options strategy for Arvinas, Inc. (ARVN)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ARVN option chain right now, and a simple map from your view on ARVN to the strategy that fits it. Model any of them in the calculator before you trade.

About ARVN

Arvinas, Inc. (ARVN) is a major company in Biotechnology. Options traders on ARVN tend to watch , since these can drive large moves in the share price.

About Arvinas, Inc.

Arvinas is a biotechnology company focused on discovering and developing drugs that eliminate disease-causing proteins from the body. The company's core technology platform centers on PROTACs—proteolysis targeting chimeras—which work by hijacking the body's natural protein disposal machinery to degrade and remove specific proteins associated with disease. The company has built a pipeline of candidates across multiple therapeutic areas. In oncology, it is pursuing treatments for cancers driven by specific mutations, including a G12D KRAS inhibitor for pancreatic, colorectal, and lung cancers, as well as a therapy targeting B-cell lymphoma 6 protein for relapsed or refractory non-Hodgkin lymphoma and an estrogen receptor degrader for hormone receptor-positive breast cancer. Beyond cancer, the company is developing treatments for neurodegenerative disease and other protein-driven conditions. Several of its programs have progressed into human clinical testing.

Arvinas generates value through partnering arrangements with established pharmaceutical companies including Pfizer, Genentech, Roche, and Bayer, which provide funding and development support for specific programs. As a…

Today's top-scoring strategy for ARVN

Our engine ranks defined-risk strategies on the live ARVN chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.

Long Call Butterfly neutral
Price: $100.00Implied volatility: 32%Expiration: 2026-07-17 (30d)
ActionQtyTypeStrikePremium
BuyCALL$95$6.83
SellCALL$100$3.82
BuyCALL$105$1.87
P/L at expiry vs today At expiry Today ±1σ
$82$100$118
Max Profit
$394
Max Loss
−$106
Net Debit (cost)
$106
Prob. of Profit
33%
Breakeven(s)
$96.06, $103.94
Implied Vol (ATM)
32%
Position Greeks
Δ
0.43
Γ
−1.202
Θ
1.69
ν
−3.16
Time decay (price held)

Simulation

Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.

Win rate
33%
Mean P/L
−$2
Median
−$106
Exp. move (1σ)
9%
5th pct
−$106
25th pct
−$106
75th pct
$96
95th pct
$333
$-100$144$388
Analyze ARVN in the calculator → Share this pick ↗

Illustrative example at ARVN's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.

Implied volatility

ARVN typically trades with moderate implied volatility, broadly in line with other large-cap stocks. Implied volatility drives option prices, so it is worth checking the live chain before you trade.

Earnings & IV crush

ARVN's next earnings report is due around August 5, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.

Key figures

Market cap
$541M
Beta (vs market)
1.75
52-week range
$6.06–$14.51
Short interest
8.1% of float · 5.5 days to cover

How to choose an options strategy for ARVN

Start with your outlook on ARVN, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:

Bullish

You expect ARVN to rise

Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.

Long Call → Bull Call Spread →

Bearish

You expect ARVN to fall

Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.

Long Put → Bear Put Spread →

Neutral

You expect ARVN to trade in a range

Sell an iron condor to collect premium while ARVN stays between two strikes, or write a covered call against shares you already own.

Iron Condor → Covered Call →

How we pick the best strategy

For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →

Open ARVN in the free calculator →

Frequently asked questions

What is the best options strategy for ARVN?

It depends on your outlook. Bullish traders often use a long call or bull call spread on ARVN; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.

Are ARVN options liquid enough to trade?

Arvinas, Inc. (ARVN) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.

How much money do I need to trade ARVN options?

Buying a single ARVN call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.

Is this financial advice?

No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ARVN or any security. Do your own research.

What does Arvinas, Inc. do?

Arvinas, Inc. (ARVN) operates in the Biotechnology industry. The "About Arvinas, Inc." section above gives a fuller picture of what the company does and how it earns money.

Does Arvinas, Inc. pay a dividend?

Arvinas, Inc. does not currently pay a dividend, so there is no ex-dividend assignment risk to plan around for options strategies.

When does Arvinas, Inc. next report earnings?

Arvinas, Inc.'s next earnings are expected around August 5, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.

Tickers related to ARVN

Comparing ARVN with similar names can help you choose the best options strategy:

KYMRKymera Therapeutics, Inc.DNLIDenali Therapeutics Inc.RCKTRocket Pharmaceuticals, Inc.CRNXCrinetics Pharmaceuticals, Inc.

Company information

Headquarters
5 Science Park, 395 Winchester Avenue, New Haven, CT, 06511, United States
Industry
Biotechnology
Employees
246
CEO
Dr. Randy Teel Ph.D.
Phone
203 535 1456
Website
www.arvinas.com

Best Options Strategy by Ticker →

Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.